Evaluating GERD Symptoms: ReQuest : Supplement Issue: Digestion 2007, Vol. 75, Suppl. 1

Evaluating GERD Symptoms: ReQuest : Supplement Issue: Digestion 2007, Vol. 75, Suppl. 1

  • ただいまウェブストアではご注文を受け付けておりません。 ⇒古書を探す
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 100 p.
  • 言語 ENG
  • 商品コード 9783805583152

Full Description

This issue is a dedicated supplement published in addition to the regular issues of 'Digestion' focussing on one specific topic. 'Digestion' is a well-respected, international peer-reviewed journal in Gastroenterology. Supplement issues are included in the subscription.

Contents

Introduction: Beglinger, C.; Systematic Review: Do We Need a New Gastro-Oesophageal Reflux Disease Questionnaire? Stanghellini, V.; Armstrong, D.; Monnikes, H.; Bardhan, K.D.; The Construction of a New Evaluative GERD Questionnaire - Methods and State of the Art: Armstrong, D.; Monnikes, H.; Bardhan, K.D.; Stanghellini, V.; Process of Measuring in Clinical Medicine - Implications of Different Definitions in Clinical Therapeutic Studies: Beckerling, A.; Braun, W.; Sommer, M.; Evaluation of GERD Symptoms during Therapy. Part I. Development of the New GERD Questionnaire ReQuest[trademark]: Bardhan, K.D.; Stanghellini, V.; Armstrong, D.; Berghofer, P.; Gatz, G.; Monnikes, H.; Evaluation of GERD Symptoms during Therapy. Part II. Psychometric Evaluation and Validation of the New Questionnaire ReQuest[trademark] in Erosive GERD: Monnikes, H.; Bardhan, K.D.; Stanghellini, V.; Berghofer, P.; Bethke, T.D.; Armstrong, D.; International Validation of ReQuest[trademark] in Patients with Endoscopy-Negative Gastro-Oesophageal Reflux Disease: Bardhan, K.D.; Stanghellini, V.; Armstrong, D.; Berghofer, P.; Gatz, G.; Monnikes, H.; Determination of ReQuest[trademark]-Based Symptom Thresholds to Define Symptom Relief in GERD Clinical Studies: Stanghellini, V.; Armstrong, D.; Monnikes, H.; Berghofer, P.; Gatz, G.; Bardhan, K.D.; Novel Measurement of Rapid Treatment Success with ReQuest[trademark]: First and Sustained Symptom Relief as Outcome Parameters in Patients with Endoscopy-Negative GERD Receiving 20 mg Pantoprazole or 20 mg Esomeprazole: Monnikes, H.; Pfaffenberger, B.; Gatz, G.; Hein, J.; Bardhan, K.D.; Pantoprazole 40 mg Is as Effective as Esomeprazole 40 mg to Relieve Symptoms of Gastroesophageal Reflux Disease after 4 Weeks of Treatment and Superior regarding the Prevention of Symptomatic Relapse: Glatzel, D.; Abdel-Qader, M.; Gatz, G.; Pfaffenberger, B.; ReQuest[trademark]: A New Questionnaire for the Simultaneous Evaluation of Symptoms and Well-Being in Patients with Gastro-Oesophageal Reflux: Ducrotte, P.; Zerbib, F.; Look - But Also Listen! ReQuest[trademark]: An Essay on a New Validated Scale to Assess the Outcome of GERD Treatment: Bardhan, K.D.; Berghofer, P.

最近チェックした商品